|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.52 GBX | +0.74% |
|
-4.28% | -16.84% |
| Jan. 28 | Bernstein reinitiates Convatec at 'outperform' | AN |
| Jan. 27 | UK's FTSE 100 rises as HSBC leads bank stocks rally | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Men's and Boys' Footwear | ||||||||||
Footwear | 773M | 908M | 1B | 877M | 788M | |||||
Total Assets | 653M | 859M | 993M | 952M | 890M | |||||
Interest Expense | -41.6M | -15M | -11.6M | -32.2M | -30.2M | |||||
Income Tax Expense | 35.2M | 33.1M | 30.5M | 23.8M | 4.3M | |||||
CAPEX | -18.6M | -25M | -51.4M | -18.2M | -8.4M | |||||
EBT | 70.9M | 214M | 159M | 93M | 8.8M | |||||
Gross Profit | 470M | 579M | 618M | 575M | 512M | |||||
D&A | 29.4M | 32M | 45.8M | 66.6M | 66.4M | |||||
Operating Income | 112M | - | - | - | - | |||||
Net Income | 35.7M | 181M | 129M | 69.2M | 4.5M |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
EMEA | 336M | 398M | 443M | 432M | 384M | |||||
D&A | - | - | - | - | 36.6M | |||||
Gross Profit | - | - | - | - | 261M | |||||
Operating Income | - | - | - | - | 77.3M | |||||
EBITDA | 115M | 144M | 146M | 141M | - | |||||
Americas | 296M | 383M | 428M | 326M | 288M | |||||
Total Assets | 34.6M | 46.1M | 72.6M | 92.2M | 77.3M | |||||
D&A | - | - | - | - | 25.7M | |||||
Gross Profit | - | - | - | - | 170M | |||||
Operating Income | - | - | - | - | 13.6M | |||||
EBITDA | 91.9M | 120M | 100M | 64.4M | - | |||||
APAC | 142M | 127M | 129M | 120M | 115M | |||||
Total Assets | 10M | 11.2M | 15.4M | 17.7M | 14M | |||||
D&A | - | - | - | - | 10.3M | |||||
Gross Profit | - | - | - | - | 81.1M | |||||
Operating Income | - | - | - | - | 16M | |||||
EBITDA | 39.7M | 32.6M | 33.8M | 31.7M | - | |||||
Total Assets | 7.2M | 250M | 252M | 252M | 252M | |||||
D&A | - | - | - | - | 4.3M | |||||
Operating Income | - | - | - | - | -46.2M | |||||
EBITDA | -22.7M | -33.4M | -35M | -39.4M | - | |||||
Less Intra Group Revenues | - | - | - | - | - | |||||
Total Assets | 33.5M | 47.3M | 63.9M | 69.5M | 60.5M | |||||
Total Assets | 241M | - | - | - | - | |||||
Other S.E Asia | - | - | - | - | - | |||||
South Korea | - | - | - | - | - | |||||
Japan | - | - | - | - | - | |||||
Continental Europe | - | - | - | - | - | |||||
UK | - | - | - | - | - | |||||
Total Assets | 52M | 60.6M | 79.4M | 83.9M | 75.3M |
- Stock Market
- Equities
- DOCS Stock
- Financials Dr. Martens plc
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















